HUE058190T2 - Enoláz inhibitorok és ezekkel történõ kezelési eljárások - Google Patents
Enoláz inhibitorok és ezekkel történõ kezelési eljárásokInfo
- Publication number
- HUE058190T2 HUE058190T2 HUE16712592A HUE16712592A HUE058190T2 HU E058190 T2 HUE058190 T2 HU E058190T2 HU E16712592 A HUE16712592 A HU E16712592A HU E16712592 A HUE16712592 A HU E16712592A HU E058190 T2 HUE058190 T2 HU E058190T2
- Authority
- HU
- Hungary
- Prior art keywords
- methods
- treatment therewith
- enolase
- inhibitors
- enolase inhibitors
- Prior art date
Links
- 102000012288 Phosphopyruvate Hydratase Human genes 0.000 title 1
- 108010022181 Phosphopyruvate Hydratase Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/5532—Seven-(or more) membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562130431P | 2015-03-09 | 2015-03-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE058190T2 true HUE058190T2 (hu) | 2022-07-28 |
Family
ID=55640880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE16712592A HUE058190T2 (hu) | 2015-03-09 | 2016-03-09 | Enoláz inhibitorok és ezekkel történõ kezelési eljárások |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10363261B2 (hu) |
| EP (2) | EP3268376B1 (hu) |
| ES (1) | ES2910024T3 (hu) |
| HU (1) | HUE058190T2 (hu) |
| PL (1) | PL3268376T3 (hu) |
| PT (1) | PT3268376T (hu) |
| WO (1) | WO2016145113A1 (hu) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020154742A1 (en) * | 2019-01-27 | 2020-07-30 | Board Of Regents, The University Of Texas System | Inhibitors of the enzyme enolase for precision oncology |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19859426A1 (de) * | 1998-12-22 | 2000-07-06 | Hassan Jomaa | Verwendung von phosphororganischen Verbindungen zur therapeutischen und prophylaktischen Behandlung von Infektionen |
| WO2010151183A1 (en) | 2009-06-23 | 2010-12-29 | Telefonaktiebolaget L M Ericsson (Publ) | Method and an arrangement for a mobile telecommunications network |
| US9452182B2 (en) | 2011-12-14 | 2016-09-27 | Board Of Regents, The University Of Texas System | Collateral gene inactivation biomarkers and targets for cancer therapy |
| JP2013133599A (ja) | 2011-12-26 | 2013-07-08 | Aisin Seiki Co Ltd | 車両のドアアウタハンドル装置 |
| WO2016014539A1 (en) * | 2014-07-22 | 2016-01-28 | The Board Of Trustees Of The University Of Illinois | Phosphonic acid compounds and screening method |
-
2016
- 2016-03-09 PT PT167125921T patent/PT3268376T/pt unknown
- 2016-03-09 EP EP16712592.1A patent/EP3268376B1/en active Active
- 2016-03-09 ES ES16712592T patent/ES2910024T3/es active Active
- 2016-03-09 EP EP22155267.2A patent/EP4011890A1/en active Pending
- 2016-03-09 US US15/557,288 patent/US10363261B2/en active Active
- 2016-03-09 PL PL16712592T patent/PL3268376T3/pl unknown
- 2016-03-09 HU HUE16712592A patent/HUE058190T2/hu unknown
- 2016-03-09 WO PCT/US2016/021609 patent/WO2016145113A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016145113A1 (en) | 2016-09-15 |
| ES2910024T3 (es) | 2022-05-11 |
| EP3268376B1 (en) | 2022-02-09 |
| EP4011890A1 (en) | 2022-06-15 |
| PT3268376T (pt) | 2022-04-08 |
| US10363261B2 (en) | 2019-07-30 |
| US20180147219A1 (en) | 2018-05-31 |
| PL3268376T3 (pl) | 2022-05-23 |
| EP3268376A1 (en) | 2018-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL283353A (en) | hpk1 inhibitors and methods of using them | |
| HK1259232A1 (zh) | Menin-mll的取代抑制劑及其使用方法 | |
| HK1249513A1 (zh) | Kras的稠合三環抑制劑及其使用方法 | |
| HK1252693A1 (zh) | Egfr抑制劑及其使用方法 | |
| EP3454945A4 (en) | ASH1L INHIBITORS AND METHODS OF TREATMENT THEREOF | |
| IL267455A (en) | Phosphodiesterase inhibitors and methods of treating bacteria | |
| IL267291A (en) | Actonucleotidase inhibitors and methods of using them | |
| HK1253049A1 (zh) | 糖基相互作用化合物及其使用方法 | |
| IL259801A (en) | ezh2 inhibitors and methods of using them | |
| GB201514756D0 (en) | Compound and method of use | |
| LT3372229T (lt) | Toninio slopinimo sustiprinimo ir angelmano sindromo gydymo būdai | |
| IL282482A (en) | Variants of protoxin-II and methods of use | |
| GB201514760D0 (en) | Compounds and method of use | |
| HK1254954A1 (zh) | Lpt-723和免疫檢查點抑制劑組合物及其治療方法 | |
| GB201609786D0 (en) | Compounds and method of use | |
| IL282508A (en) | Variants of protoxin-II and methods of use | |
| IL274504A (en) | 2ACSS inhibitors and methods of their use | |
| HK1243407A1 (zh) | Ripk2抑制劑及用其治療癌症的方法 | |
| GB201511799D0 (en) | Composition and methods of treatment | |
| GB201817198D0 (en) | Treatment ported sub and method of use | |
| IL266344A (en) | Inhibitors of mtor-deptor interactions and methods of use thereof | |
| GB201417248D0 (en) | Compostion and methods of treatment | |
| HUE058190T2 (hu) | Enoláz inhibitorok és ezekkel történõ kezelési eljárások | |
| GB201715358D0 (en) | Methods of screening and treatment with USP4 inhibitors | |
| GB201416797D0 (en) | Contianer and method of use thereof |